Stocks · Health care · Biological Products, (No Diagnostic Substances)

Denali Therapeutics Inc.

DNLI Clue Score33

United States Fiscal year ends December CIK 0001714899 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

14 insiders · 7 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ryan J. Watts

President and CEO

—

$580.77K (1)

−$580.77K

2,417,217

1.51%

$53.88M

−0.9%

Alexander O. Schuth

COFO and Secretary

—

$420.60K (3)

−$420.60K

802,744

0.5022%

$17.89M

+13.9%

Nancy Thornberry

Director

—

$261.93K (2) scheduled

−$261.93K

19,686

0.0123%

$438.80K

+5.4%

Peter Scott Chin

Chief Medical Officer

—

$36.87K (1)

−$36.87K

204,538

0.1280%

$4.56M

−0.8%

Baker Bros. Advisors LP entity

Director

—

—

—

3,422,366

2.14%

$76.28M

+1.0%

Marc Tessier-Lavigne

Director

—

—

—

1,886,576

1.18%

$42.05M

+0.3%

Carole Ho

Chief Medical Officer

—

—

—

216,585

0.1355%

$4.83M

+82.3%

Vicki L Sato

Director

—

—

—

107,976

0.0675%

$2.41M

−3.7%

Steve E. Krognes

Director

—

—

—

38,202

0.0239%

$851.52K

−35.4%

Peter S Klein

Director

—

—

—

33,941

0.0212%

$756.54K

+57.9%

Jennifer E. Cook

Director

—

—

—

32,483

0.0203%

$724.05K

+62.1%

Jay T Flatley

Director

—

—

—

22,628

0.0142%

$504.38K

+122.2%

David P Schenkein

Director

—

—

—

21,665

0.0136%

$482.91K

+0.8%

Hauwermeiren Timothy Van

Director

—

—

—

17,040

0.0107%

$379.82K

—